我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无批准数据
- Singapore's National Centre for Infectious Diseases has conducted the country's first COVID-19 human challenge study, deliberately exposing five vaccinated volunteers to the virus under controlled conditions. - The Sing-CoV trial aims to recruit 20 healthy participants aged 21-30 by October 2024, with researchers collecting comprehensive biological samples to gain precise insights into infection dynamics despite vaccination. - This pioneering study establishes a framework for future challenge trials, including the upcoming global MUSICC study in 2025, strengthening Singapore's preparedness for future pandemics including potential "Disease X" threats.